Dr. Jeff Hosry, MD

Dr. Hosry practices at H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida.

Dr. Hosry's NPI, 1033663976, was assigned on August 9, 2016. Dr. Hosry graduated from Lebanese University School of Medicine in 2012. Dr. Hosry holds Florida license ME169254.

Dr. Hosry's primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD, at 10901 McKinley Dr, Tampa, FL 33612.

Dr. Hosry's primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida. Dr. Hosry is also affiliated with Moffitt Cancer Hospital. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Hosry to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hosry practices, 3 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Hosry's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Hosry is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Hosry's licenses on file in 2 states: Florida and Pennsylvania.

Dmand AI lists acute skin infection, hiv/aids, joint or bone infection, pneumonia and UTI among the conditions Dr. Hosry treats.

CMS data shows 501 Medicare services from Dr. Hosry across 6 procedure codes in 2024, for 280 Medicare patients. Medicare paid $41,782 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 280 Medicare patients who saw Dr. Hosry in 2024. The largest group is 65 to 74, with 104 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 3.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hosry's median patient age at 66, with 39% women.

In 2024, Dr. Hosry wrote 322 Medicare Part D claims for 58 patients. 56% of them were for generic drugs. CMS names the drug for 225 of them, across 10 drugs with 11 or more claims each, at $399,694 in total drug cost. In 2023, CMS named 209 claims across 9 drugs.

Dr. Hosry accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hosry as offering telehealth.

Dmand AI links 21 papers to Dr. Hosry, published from 2015 to 2023. 2017 was the busiest year, with 3. The most frequent topics are Antiviral Agents, Hepacivirus and Hepatitis C, Chronic. Dr. Hosry has published most often in Am J Gastroenterol. Dr. Hosry's most frequent co-authors are Harrys Antonio Torres, MD, Minas Platon Economides, MD and Bruno Palma Granwehr, MD.

CMS Open Payments shows 8 general payments to Dr. Hosry from 3 drug and device companies from 2022 to 2023. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $81.

Dmand AI lists 5 awards for Dr. Hosry, most recently First place award, Chart Review Poster in 2021.

Dr. Hosry graduated from Lebanese University School of Medicine in 2012. Dr. Hosry is a member of Infectious Diseases Society of America.

Dr. Hosry is in network with 14 carriers, including Aetna, United Healthcare and Capital Blue Cross. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.